1. Aho K et al: HLA antigen 27 and reactive arthritis. Lancet 2:157, 1973
2. Reiter H: Uber eine bisher unerkannte Spirochateninfektion (Spirochetosis arthritica). Dtsch Med Wochensohr 42:1535, 1916
3. Parker CT, Thomas, D: Reiter's syndrome and reactive arthritis. J Am Osteopath Assoc 100:101, 2000
4. Wallace DJ, Weisman MH: The physician Hans Reiter as prisoner of war in Nuremberg: A contextual review of his interrogations (1945–1947). Semin Arthritis Rheum 32:208, 2003
5. Panush RS et al: Retraction of the suggestion to use the term “Reiter's syndrome” sixty-five years later: The legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 56:693, 2007
6. Sharp JT: Reiter's syndrome. In: Arthritis and Allied Conditions, 8th edition, edited by JH Hollander, DJ McCarthy. Philadelphia, Lea and Febiger, 1979, p. 1223
7. Sydenham T: The Works of Thomas Sydenham, M.D, vol. 198. Translated by RG Latham. London, Sydenham Society, II, 1848, p. 257
8. Stoll M: De l'arthrite dysenterique. Arch Gen Med 14:29, 1869
9. Yvan AU: Observation sur une metastase de gonorrhee. Ann Soc Med Prat de Montpellier 119-125, 1806
10. Brodie BC: Pathological and Surgical Observations on Diseases of the Joints. London, Longman, 1818, p. 54
11. Launois M PE: Arthropaties recidivantes amythrophie generalize troubles trophiques multiples. D'origine blennofthalmique. Bull Mem Soc Med Hosp Paris 14:93, 1897
12. Fiessinger M, Leroy E: Contribution a l'etude d'une epidemie de dysenterie dans le somme. Bull Soc Med Hop Paris 40:2030, 1916
13. Leirisalo-Repo M: Prognosis, course of disease and treatment of the spondyloarthropathies. Rheum Dis Clin Am 24:737, 1998
14. Carter JD: Reactive arthritis: Defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am 20:827, 2006
15. Rudwaleit M et al: Low incidence of reactive arthritis in children following a salmonella outbreak. Ann Rheum Dis 60:1055, 2001
16. Isomäki H et al: Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol 7:188, 1978
17. Kvien TK et al: Reactive arthritis: Incidence-triggering agents and clinical presentation. J Rheumatol 21:115, 1994
18. Michet CJ et al: Epidemiology of Reiter's syndrome in Rochester, Minnesota: 1950–1980. Arthritis Rheum 31:428, 1988
19. Braun J et al: Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58, 1998
20. Carter JD, Hudson AP: Reactive arthritis: Clinical aspects and medical management. Rheum Dis Clin North Am 35:21, 2009
21. Boyer GS et al: A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? Arch Intern Med 157:2111, 1997
22. Barth WF, Segal K: Reactive arthritis (Reiter's syndrome). Am Fam Physician 60:499, 1999
23. Schiellerup P, Krogfelt KA, Locht H: A comparison of self-reported joint symptoms following infection with different enteric pathogens: Effect of HLA-B27. J Rheumatol 35:480, 2008
24. Garg AX et al; Walkerton Health Study Investigators: A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol 59:421, 2006
25. Townes JM et al: Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: A population-based study. Ann Rheum Dis 67:1689, 2008
26. Nelson HD, Helfand M: Screening for chlamydial infection. Am J Prev Med 20:95, 2001
27. Manavi K: A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 20:941, 2006
28. Stamm WE: Chlamydia trachomatis infections: progress and problems. J Infect Dis 179(Suppl. 2):380, 1999
29. Carter JD et al: Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 60:1311, 2009
30. Rich E et al: Reactive arthritis in patients attending and urban sexually transmitted disease clinic. Arthritis Rheum 39:1172, 1996
31. Saario R, Toivanen A: Chlamydia pneumonia as a cause of reactive arthritis. Br J Rheumatol 32:1112, 1993
32. Braun J et al: Chlamydia pneumoniae – A new causitive agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 53:100, 1994
33. Hannu T, Puolakkainen M, Leirisalo-Repo M: Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) 38:411, 1999
34. Gerard HC et al: Synovial chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25:734, 1998
35. Gerard HC et al: Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 29:17, 2000
36. Gerard HC et al: Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog 36:35, 2004
37. Carter JD, Gerard HC, Hudson AP: Psoriasiform lesions induced by tumour necrosis factor antagonists: A skin-deep medical conundrum. Ann Rheum Dis 67:1181, 2008
38. Gerard HC et al: Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog 48:62, 2010
39. Mittal A: Serovar distribution of Chlamydia trachomatis isolates collected from the cervix: Use of the polymerase chain reaction and restriction endonuclease digestion. Br J Biomed Sci 55:179, 1998
40. Workowski KA et al: Clinical manifestations of genital infection due to Chlamydia trachomatis in women: Differences related to serovar. Clin Infect Dis 19:756, 1994
41. Schachter J et al: Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med 122:283, 1966
42. Gilbert RJ et al: Antibiotic therapy in experimental bedsonial arthritis. Arthritis Rheum 16:30, 1973
43. Dworkin MS et al: Reactive arthritis and Reiter's syndrome following and outbreak of gastroenteritis caused by Salmonella enteritidis. Clin Infect Dis 33:1010, 2001
44. Buxton JA et al: Reactive arthritis and other sequelae following sporadic Salmonella typhimurium infection in British Columbia, Canada: A case control study. J Rheumatol 29:2154, 2002
45. Hannu T et al: Reactive arthritis attributable to Shigella infection: A clinical and epidemiological nationwide study. Ann Rheum Dis 64:594, 2005
46. Altekruse SF et al: Campylobacter jejuni–An emerging foodborne pathogen. Emerg Infect Dis 5:28, 1999
47. Pope JE et al: Campylobacter reactive arthritis: A systematic review. Semin Arthritis Rheum 37:48, 2007
48. Hannu T et al: Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection. Ann Rheum Dis 62:866, 2003
49. Press N et al: Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib. Scand J Infect Dis 33:523, 2001
50. Braun J et al: Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 24:1092, 1997
51. Granfors K et al: Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 19:500, 1992
52. Nikkari S et al: Salmonella-triggered reactive arthritis: Use of polymerase chain reaction, immunocytochemical staining, and gas-chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 42:84, 1999
53. Gaston JS, Cox C, Granfors K: Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum 42:2239, 1999
54. Nikkari S et al: Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical in the detection of bacterial components from synovial specimens. Arthritis Rheum 35:682, 1992
55. Birnbaum J, Bartlett JG, Gelber
AC: Clostridium difficile: An under-recognized cause of reactive arthritis?
Clin Rheumatol 27:253, 2008
56. Tinazzi E et al: Reactive arthritis following
BCG immunotherapy for urinary bladder carcinoma: A systematic review.
Rheumatol Int 26:481, 2006
57. Calabrese LH, Kirchner E, Shrestha R: Rheumatic complications of human immunodeficiency virus infection in the era of highly active anti-retroviral therapy: Emergence of a new syndrome of a new reconstitution and changing patterns of disease. Semin Arthritis Rheum 35:166, 2005
58. Reveille JD, Ball EJ, Khan MA: HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 13:265, 2001
59. Morris R et al: HL-A W27–a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med 290:554, 1974
60. Khan MA: Clinical application of the HLA-B27 Test in rheumatic diseases. A current perspective. Arch Intern Med 140:1097, 1980
61. Inman RD et al: Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 31:1377, 1988
62. Mattila L et al: Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 33:1136, 1994
63. Mattila L et al: Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J Infect 36:289, 1998
64. Hannu T et al: Campylobacter-triggered reactive arthritis: A population-based study. Rheumatology 41:312, 2002
65. Carter JD, Valeriano J, Vasey FB: A prospective, randomized 9-month comparison of
doxycycline vs.
doxycycline and
rifampin in undifferentiated spondyloarthritis – with special reference to Chlamydia-induced arthritis.
J Rheumatol 31:1973, 2004
66. Hannu T et al: Reactive arthritis following an outbreak of Campylobacter jejuni infection. J Rheumatol 31:528, 2004
67. Kvien TK et al: Three-month treatment of reactive arthritis with
azithromycin: A EULAR double-blind, placebo-controlled study.
Ann Rheum Dis 63:1113, 2004
68. Girschick HJ et al: Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol 26:S12, 2008
69. Dulphy N et al: Common intra-articular T cell expansions in patients with reactive arthritis: Identical beta-chain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 162:3830, 1999
70. Kuon W et al: Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy. J Immunol 173:4859, 2004
71. Popov I et al: Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis. J Immunol 169:4033, 2002
72. Saarinen M et al: Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology (Oxford) 41:651, 2002
73. Colbert RA et al: From HLA-B27 to spondyloarthritis: A journey through the ER. Immunol Rev 233:181, 2010
74. Sampaio-Barros PD et al: Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: Comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int 28:483, 2008
75. Díaz-Peña R et al: Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. J Rheumatol 35:2236, 2008
76. Rihl M et al: Identification of candidate genes for susceptibility to reactive arthritis. Rheumatol Int 29:1519, 2009
77. Gérard HC et al: Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. Microb Pathog 44:279, 2008
78. Guo A et al: Adhesin-dependent binding and uptake of Salmonella enterica serovar Typhimurium by dendritic cells. Microbiology 153:1059, 2007
79. Vazquez-Torres A et al: Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: Importance of the Kupffer cell network. J Immunol 172:6202, 2004
80. Zhang X et al: Innate immunity and arthritis: Neutrophil Rac and toll-like receptor 4 expression define outcomes in infection-triggered arthritis. Arthritis Rheum 52:1297, 2005
81. Tsui FW et al: Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58:3436, 2008
82. Rihl M et al: Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma. Ann Rheum Dis 63:1673, 2004
83. Braun J et al: Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 42:2039, 1999
84. Thiel A et al: Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 43:2834, 2000
85. Yin Z et al: Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 40:1788, 1997
86. Ishihara T et al: Inhibition of chlamydia trachomatis growth by human interferon-alpha: Mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed Res 26:179, 2005
87. Perry LL, Feilzer K, Caldwell HD: Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and–Independent pathways. J Immunol 158:3344, 1997
88. Takano R et al: Cytokine response of lymphocytes persistent infected with Chlamydia pneumoniae. Curr Microbiol 50:160, 2005
89. Inman RD, Chiu B: Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum 54:499, 2006
90. Arnett FC et al: Incomplete Reiter's Syndrome: Discriminating features and HL-A W27 in diagnosis. Ann Intern Med 84:8, 1976
91. Grigoryan M et al: Imaging in spondyloarthropathies. Curr Rheumatol Rep 6:102, 2004
92. Rothschild BM, Pingitore C, Eaton M: Dactylitis: Implications for clinical practice. Semin Arthritis Rheum 28:41, 1998
93. François RJ et al: Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 43:2011, 2000
94. Hancock JAH: Surface manifestations of Reiter's disease in the male. Br J Venereal Dis 36:36, 1960
95. Schneider JM, Matthews JH, Graham BS: Reiter's syndrome. Cutis 71:198, 2003
96. Wu BI, Schwartz RA: Reiter's syndrome: The classic triad and more. J Am Acad Dermatol 59:113, 2008
97. Cohen MR, Reda DJ, Clegg DO: Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752, 1999
98. Chogle AR et al: Reiter's syndrome with keratoderma blennorrhagica. J Assoc Physicians India 47:416, 1999
99. Callen JP, Mahl CF: Oculocutaneous manifestations observed in multisystem disorders. Dermatol Clin 10:709, 1992
100. Willkens RF et al: Reiter's syndrome: Evaluation of preliminary criteria for definite disease. Arthritis Rheum 24:844, 1981
101. Brook MG, Kell PD, Atia WA: Lone circinate balanitis and genital keratoderma: Underdiagnosed presentations of chlamydial infection in men? J Eur Acad Dermatol Venereol 8:34, 1997
102. Kiss S et al: Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology 110:1764, 2003
103. Cuvelier C et al: Histopathology of intestinal inflammation related to reactive arthritis. Gut 28:394, 1987
104. Olhagen B: Urogenital syndromes and spondarthritis. Br J Rheumatol 22:33, 1983
105. Yli-Kerttula UI, Kataja MJ, Vilppula AH: Urinary genital involvements in rheumatic disorders in females. An interview study. Clin Rheumatol 4:170, 1985
106. Hannu T et al: Cardiac findings of reactive arthritis: An observational echocardiographic study. Rheumatol Int 21:169, 2002
107. Bergfeldt L: HLA-B27-associated cardiac disease. Ann Intern Med 127:621, 1997
108. Kingsley G, Sieper J: Third International Workshop on Reactive Arthritis. 23–26 September 1995, Berlin, Germany. Ann Rheum Dis 55:564, 1996
109. Braun J et al: On the difficulties of establishing a consensus on the definition of and diagnostic investigations of reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3–6, 1999. J Rheumatol 27:2185, 2000
110. Siala M et al: Detection and frequency of Chlamydia trachomatis DNA in synovial samples from Tunisian patients with reactive arthritis and undifferentiated oligoarthritis. FEMS Immunol Med Microbiol 55:178, 2009
111. Schnarr S et al: Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: Results of a prospective study. Arthritis Rheum 44:2679, 2001
112. Wollenhaupt J, Schnarr S, Kuipers JG: Bacterial antigens in reactive arthritis and spondarthritis. Rational use of laboratory testing in diagnosis and follow-up. Baillieres Clin Rheumatol 12:627, 1998
113. Lassus A: A comparative pilot study of azapropazone and
indomethacin in the treatment of psoriatic arthritis and Reiter's disease.
Curr Med Res Opin 4:65, 1976
114. Juvakowski T, Lassus A: A double-clind cross-over evaluation of
ketoprofen and
indomethacin in Reiter's disease.
Scand J Rheumatol 11:106, 1982
115. Flores D et al: Reactive arthritis: Newer developments. Rheum Dis Clin North Am 29:37, 2003
116. Thiers BH: The use of topical
calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
J Am Acad Dermatol 37:S69, 1997
117. Egsmose C et al: Limited effect of
sulfasalazine treatment in reactive arthritis. A randomized double blind placebo controlled trial.
Ann Rheum Dis 56:32, 1997
118. Clegg DO et al: Comparison of
sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.
Arthritis Rheum 39:2021, 1996
119. Flagg SD et al: Decreased pain and synovial inflammation after
etanercept therapy in patients with reactive and undifferentiated arthritis: An open-label trial.
Arthritis Rheum 53:613, 2005
120. Haibel H, Brandt J, Rudawaleit M: Therapy of chronic enteral reactive arthritis with
infliximab [abstract].
Ann Rheum Dis 62:AB0380, 2003
121. Oili KS et al: Treatment of reactive arthritis with
infliximab.
Scand J Rheumatol 32:122, 2003
122. Schrafranski MD:
Infliximab for reactive arthritis secondary to Chalmydia trachomatis infection.
Rheumatol Int 30:679, 2010
123. Ko JM, Gottlieb AB, Kerbleski JF: Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. J Dermatolog Treat 20:100, 2009
124. Lauhio A et al: Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 34:6, 1991
125. Smieja M et al: Randomised, blinded, placebo controlled trial of
doxycycline for chronic seronegative arthritis.
Ann Rheum Dis 60:1088, 2001
126. Wakefield D et al:
Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis.
Arthritis Rheum 42:1894, 1999
127. Yli-Kerttula T et al: Effect of a three month course of
ciprofloxacin on the outcome of reactive arthritis.
Ann Rheum Dis 59:565, 2000
128. Sieper J et al: No benefit of long-term
ciprofloxacin in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study.
Arthritis Rheum 42:1386, 1999
129. Carter JD et al: Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis. Arthritis Rheum Feb 12, 2010. [Epub ahead of print]